Thursday, July 3, 2025
CN
  • About
  • Advertise
  • Careers
  • Contact
Money Compass
  • Home
  • Financial News
  • Investment News
  • Other News
    • Bursa News
    • Government News
    • Listing Companies News
    • Oversea Financial & Investment News
  • Interviews
    • Features Interviews
    • Corporate Interviews
  • Financial & Investment Articles
  • PR Newswire
  • Login
No Result
View All Result
Money Compass
Home PR Newswire

Gwo Xi Stem Cell Company Powers Local Regenerative Medicine, Partners with Japan to Open a New Era

Money Compass by Money Compass
July 3, 2025
in PR Newswire
0
Gwo Xi Stem Cell Company Powers Local Regenerative Medicine, Partners with Japan to Open a New Era
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

HSINCHU, July 3, 2025 /PRNewswire/ — Gwo Xi Stem Cell Applied Technology Co., Ltd. (TPEx: 6704) is a clinical-stage cell therapy company headquartered in Hsinchu, Taiwan, advancing mesenchymal stem cell (MSCs) therapies. Leveraging its patented technologies, the company’s platform provides safer and potent therapies with solid evidence, which there are four stem cell therapy products have been verified by human clinical trials, and two of them have progressed toward phase III. In addition, the one targeting chronic stroke, GXNPC1®, is applying the conditional and time-limited 5-year approval in Taiwan to rapidly put the product into market, marking a significant milestone toward commercialization and international drug licensing transaction opportunities.


Gwo Xi has developed four stem cell therapy products, two of which are progressing toward Phase III clinical trials.

In addition to MSCs, exosomes are now being vigorously developed. Gwo Xi has adopted proprietary cell culture technologies to advance its exosome quality and potency. The exosome processed by Gwo Xi’s platform, YBTTM, has been officially granted International Nomenclature of Cosmetic Ingredients (INCI) (INCI name: Human Adipose-Derived MSC Exosome, Mono ID: 37487). The YBTTM is well-positioned for clinical applications employing GMP standards, which can be applied to cosmetic products, aesthetic medicine, and regenerative medicine.

Related posts

JW Marriott Phu Quoc Unlocks a Season of Discovery with New Summer Offer

JW Marriott Phu Quoc Unlocks a Season of Discovery with New Summer Offer

July 3, 2025
Vantage Markets Celebrates Award and Successful Debut at Wealth Expo Peru 2025

Vantage Markets Celebrates Award and Successful Debut at Wealth Expo Peru 2025

July 3, 2025

With an integrated platform focusing on regenerative medicine, Gwo Xi has established a PIC/S GMP-grade cell preparation factory in Hsinchu, Taiwan. The company offers comprehensive CDMO/CMO services for both stem cells and exosomes, solidifying its role as a key player in the global regenerative medicine supply chain.

Japan, recognized as a global leader in regenerative medicine, is projected to reach a market size of JPY 797.8 billion by 2030, according to a report by Fuji Keizai. Gwo Xi is actively seeking Japanese partners for drug licensing transactions, co-development, and clinical trial collaboration. Moreover, for cosmetic market, Gwo Xi is looking for partnership with premium skincare brands to co-develop anti-aging products possessing regenerative properties, ushering in a new era of advanced beauty solutions.

From July 9 to 11, the INTERPHEX Week and Regenerative Medicine Expo Tokyo will be held at Tokyo Big Sight, showcasing the latest technologies from the international pharmaceutical and regenerative medicine industries. During the exhibition, Gwo Xi will show the commodification process of four stem cell therapy products, including the safety and efficacy results in clinical trials, alongside applications of its MSC-derived exosomes.  Welcome to join this prestigious international medical event in Japan.

Press Contact
Roy Tsai,Tina Zheng
Phone: 886-3-6585959 
Mail: [email protected] 
Gwo Xi Stem Cell Applied Technology Co., Ltd.

Cision View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/gwo-xi-stem-cell-company-powers-local-regenerative-medicine-partners-with-japan-to-open-a-new-era-302490436.html

SOURCE Gwo Xi Stem Cell Applied Technology Co., Ltd.

​ 

Previous Post

Eye Level Malaysia Ignites Learning Joy with Mid-Year Promo & Exclusive Block Sets!

Next Post

Motorola launches its most intelligent smartphones yet – the motorola razr 60 and motorola edge 60 pro

Next Post
Motorola launches its most intelligent smartphones yet – the motorola razr 60 and motorola edge 60 pro

Motorola launches its most intelligent smartphones yet - the motorola razr 60 and motorola edge 60 pro

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

BROWSE BY CATEGORIES

  • Blog
  • Bursa News
  • Corporate Interviews
  • Features Interviews
  • Financial & Investment Articles
  • Financial News
  • Government News
  • Investment News
  • Listing Companies News
  • Oversea Financial & Investment News
  • PR Newswire

BROWSE BY TOPICS

2018 League Balinese Culture Bali United Budget Travel business Champions League Chopper Bike Doctor Terawan industrial Istana Negara Malaysia Market Stories National Exam net zero emissions targets 2025 Renewable energy Visit Bali

Recent News

  • JW Marriott Phu Quoc Unlocks a Season of Discovery with New Summer Offer
  • Vantage Foundation Joins Hands with KDM Foundation to Empower Street Children in Jakarta
  • Vantage Markets Celebrates Award and Successful Debut at Wealth Expo Peru 2025

Category

  • Blog
  • Bursa News
  • Corporate Interviews
  • Features Interviews
  • Financial & Investment Articles
  • Financial News
  • Government News
  • Investment News
  • Listing Companies News
  • Oversea Financial & Investment News
  • PR Newswire
  • About
  • Advertise
  • Careers
  • Contact

Copyright © 2024 Money Compass Media (M) Sdn Bhd. All Rights Reserved

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Features Interviews
  • Government News
  • Financial News
  • Investment News
  • Listing Companies News
  • Corporate Interviews
  • Bursa News
  • Financial & Investment Articles
  • Oversea Financial & Investment News

Copyright © 2024 Money Compass Media (M) Sdn Bhd. All Rights Reserved